Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 46.75T | 48.04T | 45.10T | 37.15T | 31.38T | 27.21T |
Gross Profit | 9.50T | 9.58T | 9.37T | 6.31T | 5.97T | 4.83T |
EBITDA | 8.62T | 8.75T | 8.39T | 5.19T | 5.84T | 4.61T |
Net Income | 5.10T | 4.77T | 4.94T | 2.45T | 2.85T | 2.25T |
Balance Sheet | ||||||
Total Assets | 94.67T | 93.60T | 90.11T | 74.30T | 67.69T | 62.27T |
Cash, Cash Equivalents and Short-Term Investments | 13.88T | 15.92T | 14.11T | 9.23T | 8.62T | 9.32T |
Total Debt | 39.58T | 38.79T | 36.56T | 29.38T | 26.50T | 25.66T |
Total Liabilities | 57.82T | 56.72T | 54.87T | 45.04T | 40.53T | 37.98T |
Stockholders Equity | 35.91T | 35.92T | 34.22T | 28.34T | 26.25T | 23.40T |
Cash Flow | ||||||
Free Cash Flow | -1.60T | -1.56T | -842.02B | -750.76B | -107.63B | -1.04T |
Operating Cash Flow | 4.24T | 3.70T | 4.21T | 2.96T | 3.72T | 2.73T |
Investing Cash Flow | -4.29T | -4.19T | -5.00T | -1.60T | -577.50B | -4.68T |
Financing Cash Flow | 391.01B | 197.24B | 2.50T | -56.18B | -2.47T | 2.74T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $237.02B | 7.70 | 13.36% | 3.01% | 1.06% | -7.05% | |
77 Outperform | $995.76B | 178.78 | 8.43% | ― | -2.73% | -51.64% | |
72 Outperform | $50.06B | 8.37 | 7.07% | 0.97% | 5.34% | -28.29% | |
71 Outperform | $44.02B | 14.11 | 7.11% | 6.93% | 2.72% | -17.58% | |
71 Outperform | $50.61B | 8.98 | 5.17% | 4.33% | 0.83% | -26.70% | |
68 Neutral | $26.26B | 22.92 | 12.22% | ― | 10.28% | -29.75% | |
57 Neutral | HK$24.67B | 3.83 | -3.22% | 5.89% | 0.28% | -59.63% |